LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.

    Han, Meifang / Ma, Ke / Wang, Xiaojing / Yan, Weiming / Wang, Hongwu / You, Jie / Wang, Qiuxia / Chen, Huilong / Guo, Wei / Chen, Tao / Ning, Qin / Luo, Xiaoping

    Frontiers in endocrinology

    2021  Volume 12, Page(s) 596518

    Abstract: ... diabetes mellitus (T2DM) among COVID-19 patients.: Design and methods: In this retrospective study, the clinical ... and immunological characteristics of 306 hospitalized confirmed COVID-19 patients (including 129 ... the effect of type 2 diabetes (T2DM) or hyperglycemia on the immune system among COVID-19 disease has ...

    Abstract Clinical trial registration: www.ClinicalTrials.gov, identifier: NCT04365634.
    Context: Diabetes mellitus was associated with increased severity and mortality of disease in COVID-19 pneumonia. So far the effect of type 2 diabetes (T2DM) or hyperglycemia on the immune system among COVID-19 disease has remained unclear.
    Objective: We aim to explore the clinical and immunological features of type 2 diabetes mellitus (T2DM) among COVID-19 patients.
    Design and methods: In this retrospective study, the clinical and immunological characteristics of 306 hospitalized confirmed COVID-19 patients (including 129 diabetic and 177 non-diabetic patients) were analyzed. The serum concentrations of laboratory parameters including cytokines and numbers of immune cells were measured and compared between diabetic and non-diabetic groups.
    Results: Compared with non-diabetic group, diabetic cases more frequently had lymphopenia and hyperglycemia, with higher levels of urea nitrogen, myoglobin, D-dimer and ferritin. Diabetic cases indicated the obviously elevated mortality and the higher levels of cytokines IL-2R, IL-6, IL-8, IL-10, and TNF-α, as well as the distinctly reduced Th1/Th2 cytokines ratios compared with non-diabetic cases. The longitudinal assays showed that compared to that at week 1, the levels of IL-6 and IL-8 were significantly elevated at week 2 after admission in non-survivors of diabetic cases, whereas there were greatly reductions from week 1 to week 2 in survivors of diabetic cases. Compared with survival diabetic patients, non-survival diabetic cases displayed distinct higher serum concentrations of IL-2R, IL-6, IL-8, IL-10, TNF-α, and lower Th1/Th2 cytokines ratios at week 2. Samples from a subset of participants were evaluated by flow cytometry for the immune cells. The counts of peripheral total T lymphocytes, CD4
    Conclusion: The elevated cytokines, imbalance of Th1/Th2 cytokines ratios and reduced of peripheral numbers of CD8
    MeSH term(s) Adult ; Aged ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/pathology ; COVID-19/blood ; COVID-19/complications ; COVID-19/immunology ; COVID-19/mortality ; China/epidemiology ; Cytokines/analysis ; Cytokines/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/immunology ; Diabetes Mellitus, Type 2/mortality ; Female ; Humans ; Hyperglycemia/blood ; Hyperglycemia/complications ; Hyperglycemia/immunology ; Hyperglycemia/mortality ; Immune System/metabolism ; Immune System/pathology ; Killer Cells, Natural/pathology ; Lymphocyte Count ; Lymphopenia/blood ; Lymphopenia/complications ; Lymphopenia/immunology ; Lymphopenia/mortality ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2/immunology ; SARS-CoV-2/physiology ; Th1 Cells/pathology ; Th2 Cells/pathology
    Chemical Substances Cytokines
    Language English
    Publishing date 2021-03-11
    Publishing country Switzerland
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2021.596518
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical and immunological characteristics of children diagnosed with-Type 1 diabetes during the COVID-19 pandemic.

    Margolis, Merav Gil / Weizman, Sarit / Lazar, Liora / Yakobovich-Gavan, Michal / Tenenbaum, Ariel / Phillip, Moshe / Oron, Tal

    Diabetic medicine : a journal of the British Diabetic Association

    2023  Volume 41, Issue 5, Page(s) e15250

    Abstract: Aims: To find clinical and immunological signatures of the SARS-CoV-2 and the COVID-19 pandemic ... islet antibodies (IA) were significantly more common among patients in the pre-COVID-19 group compared ... the year before and during the first 2 years of the COVID-19 pandemic. Data extracted ...

    Abstract Aims: To find clinical and immunological signatures of the SARS-CoV-2 and the COVID-19 pandemic on children newly diagnosed with type 1 diabetes (T1D).
    Methods: A single-centre, retrospective, observational study comparing the clinical and immunological characteristics of children diagnosed with T1D the year before and during the first 2 years of the COVID-19 pandemic. Data extracted from the medical records included clinical and demographic parameters, COVID-19 PCR results and the presence of anti-islet, thyroid and celiac-related antibodies. Also obtained from the medical records was a family history of T1D, celiac disease and autoimmune thyroid disease in a first-degree family member.
    Results: A total of 376 children were diagnosed with T1D during the study period. A total of 132 in the pre-COVID era and 246 in the first 2 years of the pandemic. At diagnosis, the pH in children with DKA was lower, and HbA1c tended to be higher in the COVID-19 group compared to the pre-COVID-19 group (7.30 [7.18, 7.35] vs 7.33 [7.19, 7.36], p = 0.046) and (110.9 [86.9, 129.5] vs 100 [80.3, 129.5], p = 0.067]) respectively. Multiple islet antibodies (IA) were significantly more common among patients in the pre-COVID-19 group compared to the COVID-19 group (72% vs 61%, p = 0.032). Tissue transglutaminase antibodies were more common among children diagnosed in the COVID-19 compared to the pre-COVID group (16.6% vs 7.9%, p = 0.022).
    Conclusions: Our findings suggest that SARS-CoV-2 and the environmental alterations caused by the pandemic affected the clinical characteristics and the immunological profile of children diagnosed with T1D. It is, therefore, plausible that the virus plays a role in the autoimmune process causing T1D.
    MeSH term(s) Child ; Humans ; Diabetes Mellitus, Type 1/epidemiology ; Pandemics ; Retrospective Studies ; COVID-19/epidemiology ; SARS-CoV-2 ; Diabetic Ketoacidosis
    Language English
    Publishing date 2023-11-14
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 605769-x
    ISSN 1464-5491 ; 0742-3071 ; 1466-5468
    ISSN (online) 1464-5491
    ISSN 0742-3071 ; 1466-5468
    DOI 10.1111/dme.15250
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.

    Zhao, Ruxing / Sun, Yujing / Zhang, Yongyuan / Wang, Weili / Wang, Shouyu / Wang, Chuang / Liu, Jinbo / Gao, Ling / Hu, Zhao / Fei, Jianchun / Hou, Xinguo / Zheng, Huizhen / Chen, Li

    Mediators of inflammation

    2020  Volume 2020, Page(s) 6914878

    Abstract: ... diabetes (T2D) affects the immunological response in COVID-19 patients.: Methods: We conducted ... a retrospective pilot study investigating immunological characteristics of confirmed cases of COVID-19 with or ... were higher in the T2D group than in the NDM group (: Conclusions: The COVID-19 patients comorbid ...

    Abstract Background: COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has threatened every civilian as a global pandemic. The immune system poses the critical interactive chain between the human body and the virus. Here, we make efforts to examine whether comorbidity with type 2 diabetes (T2D) affects the immunological response in COVID-19 patients.
    Methods: We conducted a retrospective pilot study investigating immunological characteristics of confirmed cases of COVID-19 with or without comorbid T2D. Two subcohorts of sex- and age-matched participants were eligible for data analysis, of which 33 participants were with T2D and the remaining 37 were nondiabetic (NDM). Cellular immunity was assessed by flow cytometric determination of surface markers including CD3, CD4, CD8, CD19, CD16, and CD56 in peripheral blood. Levels of C reactive protein, immunoglobulin (IgG, IgM, IgA, and IgE), and complements (C3, C4) were detected by rate nephelometry immunoassay. And Th1/Th2 cytokines (IL-2, IL-4, IL-6, IL-10, TNF-
    Results: Neutrophil counts were found to be significantly higher in the T2D group than in the NDM group and had a significant relevance with clinical severity. Lymphocyte frequencies showed no significant differences in the two groups. However, the proportions and absolute counts of T, Tc, Th, and NK cells decreased in both groups to different degrees. An abnormal increase in neutrophil count and a decrease in lymphocyte subpopulations may represent risk factors of COVID-19 severity. The level of IgG, IgM, IgA, C3, and C4 showed no significant difference between the two groups, while the IgE levels were higher in the T2D group than in the NDM group (
    Conclusions: The COVID-19 patients comorbid with T2D demonstrated distinguishable immunological parameters, which represented clinical relevancies with the predisposed disease severity in T2D.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Betacoronavirus ; COVID-19 ; China/epidemiology ; Cohort Studies ; Comorbidity ; Complement System Proteins/metabolism ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Cytokines/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/immunology ; Female ; Humans ; Immunity, Cellular ; Immunoglobulins/blood ; Inflammation Mediators/blood ; Lymphocyte Count ; Male ; Middle Aged ; Pandemics ; Pilot Projects ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Retrospective Studies ; SARS-CoV-2 ; Th1 Cells/immunology ; Th2 Cells/immunology
    Chemical Substances Cytokines ; Immunoglobulins ; Inflammation Mediators ; Complement System Proteins (9007-36-7)
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1137605-3
    ISSN 1466-1861 ; 0962-9351
    ISSN (online) 1466-1861
    ISSN 0962-9351
    DOI 10.1155/2020/6914878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Looks Like Neurosyphilis, Feels Like Guillain-Barre: At the Confluence of Infection and Immunology.

    Berger, Joseph I / Vernon, Kasun / Abdo, Farid / Gulati, Sandeep / Hariharan, Radhika

    Cureus

    2022  Volume 14, Issue 6, Page(s) e26318

    Abstract: ... insulin-dependent diabetes mellitus (T2IDDM) without neuropathy, coronavirus disease 2019 (COVID-19) in April 2020 without residual ... We present a 51-year-old male, with a past medical history of type 2 ... in his lower extremities and ascending toward his pelvis. Notably, he received the second dose of his Moderna COVID-19 ...

    Abstract We present a 51-year-old male, with a past medical history of type 2 insulin-dependent diabetes mellitus (T2IDDM) without neuropathy, coronavirus disease 2019 (COVID-19) in April 2020 without residual symptoms, Raynaud's, and recent occupational outdoor exposure to insects as a construction manager who came to the emergency room complaining of a three-week history of bilateral progressive numbness and weakness beginning in his lower extremities and ascending toward his pelvis. Notably, he received the second dose of his Moderna COVID-19 vaccine one week prior to symptom onset and four weeks prior to admission. He also reported a recent appearance of a maculopapular rash on his upper extremities and flanks. Physical exam was remarkable for bilateral distal motor weakness in the upper and lower extremities with associated paresthesia and decreased reflexes in the lower extremities. The patient had slight ataxia and difficulty with heel walk and toe walk. Notably, the cranial nerve exam was normal, and the patient was afebrile. Intravenous immune globulin (IVIG) was started empirically for the treatment of Guillain-Barre syndrome (GBS), and doxycycline 100mg intravenous twice a day and ceftriaxone 2g intravenous daily were started for possible tick-borne disease. Subsequently, rapid plasma reagin (RPR) returned reactive at 1:64, and cerebral spinal fluid (CSF) venereal disease research laboratory (VDRL) test was reactive at 1:2 with markedly elevated protein and pleocytosis. Human immunodeficiency virus (HIV) testing was negative. Lyme disease testing was negative. Nerve conduction studies (NCS) and electromyography (EMG) showed a sensorimotor polyneuropathy with mixed demyelinating and axonal features. IVIG was continued for a total of five days, and antibiotics were changed to penicillin G (PCN G) for a total of 14 days for definitive treatment of early neurosyphilis (NS). While both clinical and laboratory findings confirm a positive diagnosis of NS, the patient's CSF composition showed very elevated total protein levels and pleocytosis. Additionally, his early peripheral neuropathy and EMG findings are not characteristics of a single disease and, instead, suggested a mixed pathology. We postulate that this patient had confirmed secondary syphilis with early NS associated with, and possibly correlated with, a simultaneous episode of acute inflammatory demyelinating polyneuropathy (AIDP) and/or a vaccine-related phenomenon.
    Language English
    Publishing date 2022-06-25
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.26318
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top